EstechPharma Co Ltd
KOSDAQ:041910
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EstechPharma Co Ltd
Revenue
EstechPharma Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
EstechPharma Co Ltd
KOSDAQ:041910
|
Revenue
₩55.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
2%
|
|
|
Yuhan Corp
KRX:000100
|
Revenue
₩2.2T
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
7%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Revenue
₩706.7B
|
CAGR 3-Years
42%
|
CAGR 5-Years
94%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Revenue
₩1.5T
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Revenue
₩231.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
6%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Revenue
₩72.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
EstechPharma Co Ltd
Glance View
Estechpharma Co., Ltd. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 162 full-time employees. The company went IPO on 2004-02-06. The Company’s products include remedies for alcoholism, anti-inflammatory, muscle relaxant, anti-septic, anti-spasmodic, anti-cataract, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, anti-histamine, anti-ulcerants, anti-rheumatics, anti-anemia, anti-diabetic, insecticide, anti-hypertensive, anti-asthmatic and anti-depressants, among others. The company has a research and development institute, which develops APIs. The firm distributes its products within domestic market and to overseas markets.
See Also
What is EstechPharma Co Ltd's Revenue?
Revenue
55.5B
KRW
Based on the financial report for Dec 31, 2025, EstechPharma Co Ltd's Revenue amounts to 55.5B KRW.
What is EstechPharma Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for EstechPharma Co Ltd have been -4% over the past three years , -2% over the past five years , and 2% over the past ten years .
